…
XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction materials, chemicals, petrochemicals, and metals and mining industries in Australia, Canada, and Europe. It operates through Capital Equipment, Precious Metals, and Consumables segments. The Capital Equipment segment manufactures sample preparation products and analytical instruments. Its Precious Metals segment manufactures products for the laboratory and industrial platinum alloy markets. The Consumables segment manufactures chemicals and other supplies for analytical laboratories. It also provides electric and gas fusion machines, flux weighing, fusion flux, and fusion labware products; reference materials, including drift monitors, fused calibration beads, and synthetic iron ore; pressing consumables and xrTab binder tablets; zirconium crucibles; laboratory jaw crushers and containerised laboratories; press and pellet press dies; water dispensing systems; platinum beakers, crucibles, and dishes; and platinum products, such as electrodes, ICP components, customised platinum components, and semi-finished products. In addition, the company offers instruments comprising thermogravimetric analysis; CGA elemental analysers; pH, conductivity, and acid base titration; and weighing systems, as well as product recycling services. XRF Scientific Limited was founded in 1972 and is based in Osborne Park, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
XRF Scientific Limited is an Australian-listed supplier of analytical instruments, consumables and laboratory services for elemental and materials testing across mining, environmental and industrial markets. Long-term growth could be supported by demand for on-site and lab analysis, recurring consumables and service revenue, and tightening environmental and resource-sector testing requirements, making it attractive for investors seeking exposure to a niche technical supplier.
Principal risks are cyclicality linked to mining and commodities, competition from larger instrument makers, manufacturing and supply-chain execution risk, and foreign-exchange sensitivity.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | 15.37M | 14.59M | 13.46M | 11.79M | 8.19M |
| Minority interest | - | 0.05M | -0.61M | -0.50M | -0.01M |
| Net income | 10.49M | 10.38M | 8.89M | 7.69M | 6.08M |
| Selling general administrative | - | 11.84M | 11.81M | 10.14M | 8.53M |
| Selling and marketing expenses | - | 1.09M | 0.95M | - | - |
| Gross profit | 30.10M | 28.79M | 26.27M | 22.90M | 17.32M |
| Reconciled depreciation | - | 1.69M | 1.57M | 1.20M | 1.18M |
| Ebit | 17.02M | 14.82M | 13.75M | 12.01M | 8.26M |
| Ebitda | 18.72M | 15.63M | 15.32M | 13.22M | 9.44M |
| Depreciation and amortization | 1.71M | 0.81M | 1.57M | 1.20M | 1.18M |
| Operating income | 17.02M | 15.77M | 14.45M | 11.97M | 8.23M |
| Other operating expenses | 47.11M | 43.68M | 45.46M | 21.31M | 13.63M |
| Interest expense | 0.13M | 0.26M | 0.29M | 0.22M | 0.07M |
| Tax provision | - | 4.25M | 3.97M | 3.61M | 2.10M |
| Interest income | - | 0.26M | 0.28M | 0.09M | 0.00M |
| Net interest income | - | 0.01M | -0.01M | -0.14M | -0.07M |
| Income tax expense | 4.88M | 4.25M | 3.97M | 3.61M | 2.10M |
| Total revenue | 64.13M | 59.45M | 59.84M | 55.17M | 40.01M |
| Total operating expenses | 13.09M | 13.02M | 10.56M | 12.22M | 10.27M |
| Cost of revenue | 34.02M | 30.65M | 33.57M | 32.28M | 22.69M |
| Total other income expense net | -1.64M | -1.18M | -0.99M | 0.04M | 0.03M |
| Net income from continuing ops | - | 10.34M | 9.50M | 8.18M | 6.09M |
| Net income applicable to common shares | - | 10.38M | 8.89M | 7.69M | 6.08M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 78.65M | 72.79M | 68.23M | 65.55M | 55.56M |
| Intangible assets | 3.80M | 1.45M | 1.20M | 1.35M | 1.49M |
| Other current assets | 1.19M | 0.05M | 0.61M | 0.11M | 0.05M |
| Total liab | 12.26M | 12.62M | 12.69M | 15.97M | 12.21M |
| Total stockholder equity | 66.40M | 60.17M | 54.89M | 49.25M | 43.48M |
| Deferred long term liab | - | - | - | 0.86M | 0.93M |
| Other current liab | 6.02M | 1.14M | 5.68M | 2.40M | 0.89M |
| Common stock | 28.16M | - | 21.41M | 20.41M | 19.63M |
| Capital stock | - | 24.96M | 21.41M | 20.41M | 19.63M |
| Retained earnings | 36.34M | 32.23M | 31.78M | 26.65M | 22.37M |
| Other liab | - | - | - | 1.42M | 0.71M |
| Good will | 20.12M | 15.84M | 15.42M | 15.52M | 15.46M |
| Other assets | - | - | 0.00M | 1.74M | 1.96M |
| Cash | 9.46M | 12.23M | 12.05M | 10.40M | 6.65M |
| Total current liabilities | 8.34M | 9.54M | 10.45M | 11.62M | 9.66M |
| Current deferred revenue | 0.36M | - | 1.29M | 6.88M | 6.03M |
| Net debt | -7.12M | - | -8.67M | -6.09M | -3.14M |
| Short term debt | 0.87M | - | 2.23M | 1.39M | 1.67M |
| Short long term debt | - | 0.17M | 1.62M | 0.78M | 1.30M |
| Short long term debt total | 2.34M | - | 3.38M | 4.31M | 3.51M |
| Other stockholder equity | - | - | - | -47.07M | -42.00M |
| Property plant equipment | - | - | - | 10.41M | 8.66M |
| Total current assets | 41.40M | 41.96M | 39.20M | 36.53M | 28.91M |
| Net tangible assets | - | - | - | 33.25M | 27.46M |
| Short term investments | - | - | - | 5.00M | 0.00M |
| Net receivables | 9.74M | 10.02M | 9.52M | 8.63M | 6.23M |
| Long term debt | - | 0.94M | - | 1.29M | 1.46M |
| Inventory | 21.02M | 18.83M | 17.02M | 16.88M | 15.52M |
| Accounts payable | 1.10M | 1.02M | 1.25M | 0.96M | 1.07M |
| Accumulated other comprehensive income | 1.90M | - | 1.70M | 2.19M | 1.48M |
| Non currrent assets other | - | - | 1.20M | -26.42M | -24.68M |
| Non current assets total | 37.25M | 30.82M | 29.03M | 29.02M | 26.64M |
| Capital lease obligations | - | 1.76M | 1.76M | 2.24M | 0.75M |
| Long term debt total | - | - | - | 2.93M | 1.84M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | - | -2.21M | -1.64M | -0.78M | -1.11M |
| Change to liabilities | - | - | - | 0.91M | 1.16M |
| Total cashflows from investing activities | -8.17M | -2.21M | - | -0.78M | -1.11M |
| Net borrowings | - | -0.50M | - | -1.20M | 1.48M |
| Total cash from financing activities | -5.99M | -7.75M | -4.80M | -3.88M | -0.65M |
| Change to operating activities | - | - | - | 0.58M | -0.53M |
| Net income | 10.49M | 10.38M | 8.89M | 7.69M | 6.08M |
| Change in cash | -2.77M | 0.18M | 1.65M | 3.75M | 1.39M |
| Begin period cash flow | 12.23M | 12.05M | 10.40M | 6.65M | 5.26M |
| End period cash flow | 9.46M | 12.23M | 12.05M | 10.40M | 6.65M |
| Total cash from operating activities | 11.39M | 10.14M | 8.09M | 8.42M | 3.15M |
| Depreciation | 1.71M | 1.69M | 1.57M | 1.20M | 1.18M |
| Other cashflows from investing activities | - | 0.49M | -0.03M | -0.02M | -0.14M |
| Dividends paid | 5.02M | -4.52M | 3.60M | 2.68M | 2.13M |
| Change to inventory | -2.19M | -1.82M | -0.14M | -1.36M | -3.01M |
| Change to account receivables | 0.54M | -0.75M | -0.89M | -2.40M | -1.75M |
| Other cashflows from financing activities | -0.80M | -1.96M | -0.75M | -0.51M | -0.47M |
| Change to netincome | - | - | - | 1.14M | -0.13M |
| Capital expenditures | 1.70M | 1.75M | 1.61M | 0.78M | 0.52M |
| Change in working capital | -1.36M | -2.00M | -3.22M | -1.61M | -4.09M |
| Stock based compensation | - | 0.75M | - | 0.33M | 0.06M |
| Other non cash items | 0.55M | -0.69M | 11.31M | 6.38M | -0.19M |
| Free cash flow | 9.69M | 8.39M | 6.45M | 7.63M | 2.63M |
Sector: Industrials Industry: Conglomerates
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| XRF XRF Scientific Ltd |
-0.03 1.42% |
2.08 | 29.71 | 22.99 | 4.67 | 4.51 | 4.56 | 16.98 |
| SGH SGH Ltd |
-0.02 0.05% |
42.46 | 26.39 | 18.21 | 1.63 | 3.29 | 2.07 | 12.90 |
| IFT Infratil Ltd |
-0.18 1.69% |
10.49 | 44.46 | 35.34 | 3.06 | 1.66 | 6.78 | 17.02 |
| NWH NRW Holdings Ltd |
-0.21 3.33% |
6.09 | 19.09 | 14.18 | 0.68 | 4.23 | 0.74 | 6.89 |
| AAL Alfabs Australia Ltd |
0.06 33.33% |
0.24 | 20.00 | - | 0.54 | 0.93 | 0.94 | 5.75 |
XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction materials, chemicals, petrochemicals, and metals and mining industries in Australia, Canada, and Europe. It operates through Capital Equipment, Precious Metals, and Consumables segments. The Capital Equipment segment manufactures sample preparation products and analytical instruments. Its Precious Metals segment manufactures products for the laboratory and industrial platinum alloy markets. The Consumables segment manufactures chemicals and other supplies for analytical laboratories. It also provides electric and gas fusion machines, flux weighing, fusion flux, and fusion labware products; reference materials, including drift monitors, fused calibration beads, and synthetic iron ore; pressing consumables and xrTab binder tablets; zirconium crucibles; laboratory jaw crushers and containerised laboratories; press and pellet press dies; water dispensing systems; platinum beakers, crucibles, and dishes; and platinum products, such as electrodes, ICP components, customised platinum components, and semi-finished products. In addition, the company offers instruments comprising thermogravimetric analysis; CGA elemental analysers; pH, conductivity, and acid base titration; and weighing systems, as well as product recycling services. XRF Scientific Limited was founded in 1972 and is based in Osborne Park, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Vance Stazzonelli | MD, Company Sec. & Director | NA |
| Mr. Andrew Watson B.Comm, CA | CFO & Joint Company Sec. | NA |
| Mr. Stephen Prossor | Bus. Devel. Mang. | NA |
| Mr. Gino Manfredi | Gen. Mang. of XRF Labware | NA |
| Mr. Robert McConnell | Gen. Mang. of XRF Technology WA | NA |
| Mr. Jeffrey Brown | Gen. Mang. of XRF Chemicals | NA |
| Mr. Vance Stazzonelli | MD, Company Secretary & Director | NA |
| Mr. Andrew Watson B.Comm, CA | CFO & Joint Company Secretary | NA |
| Mr. Stephen Prossor | Business Development Manager | NA |
| Mr. Vance Stazzonelli | MD, Company Secretary & Director | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.